Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening
Joachim Worthington(The University of Sydney), Karen Canfell(Cancer Australia), Lucie de Jonge(Erasmus MC), Marjolein J.E. Greuter(Amsterdam University Medical Centers), Veerle M.H. Coupé(Amsterdam University Medical Centers), Jean Hai Ein Yong(AstraZeneca (Canada)), Jie‐Bin Lew(The University of Sydney), Francine van Wifferen(Amsterdam University Medical Centers), Iris Lansdorp‐Vogelaar(Erasmus University Rotterdam), Eleonora Feletto(Cancer Council NSW), Rosita van den Puttelaar(Erasmus MC), Zhuolu Sun(Canadian Partnership Against Cancer)
Cited by 25
Related Papers
Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial
|BMC Cancer|2018|236
Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations
|Gastroenterology|2017|193